Bienville Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-4,825
| Closed | -$244K | – | 120 |
|
|
2019
Q2 | $244K | Buy |
4,825
+42
| +0.9% | +$2.12K | 0.03% | 151 |
|
|
2019
Q1 | $253K | Sell |
4,783
-28
| -0.6% | -$1.48K | 0.03% | 131 |
|
|
2018
Q4 | $233K | Buy |
4,811
+538
| +13% | +$26.1K | 0.05% | 129 |
|
|
2018
Q3 | $217K | Sell |
4,273
-4
| -0.1% | -$203 | 0.02% | 92 |
|
|
2018
Q2 | $218K | Buy |
4,277
+207
| +5% | +$10.6K | 0.02% | 104 |
|
|
2018
Q1 | $204K | Sell |
4,070
-2,726
| -40% | -$137K | 0.03% | 109 |
|
|
2017
Q4 | $306K | Sell |
6,796
-375
| -5% | -$16.9K | 0.05% | 130 |
|
|
2017
Q3 | $368K | Buy |
7,171
+74
| +1% | +$3.8K | 0.06% | 94 |
|
|
2017
Q2 | $387K | Buy |
7,097
+257
| +4% | +$14K | 0.11% | 91 |
|
|
2017
Q1 | $365K | Sell |
6,840
-14
| -0.2% | -$747 | 0.09% | 89 |
|
|
2016
Q4 | $334K | Sell |
6,854
-320
| -4% | -$15.6K | 0.07% | 88 |
|
|
2016
Q3 | $391K | Sell |
7,174
-298
| -4% | -$16.2K | 0.1% | 80 |
|
|
2016
Q2 | $409K | Buy |
7,472
+1,738
| +30% | +$95.1K | 0.11% | 64 |
|
|
2016
Q1 | $300K | Hold |
5,734
| – | – | 0.1% | 49 |
|
|
2015
Q4 | $293K | Hold |
5,734
| – | – | 0.1% | 44 |
|
|
2015
Q3 | $280K | Hold |
5,734
| – | – | 0.12% | 51 |
|
|
2015
Q2 | $299K | Hold |
5,734
| – | – | 0.12% | 48 |
|
|
2015
Q1 | $331K | Hold |
5,734
| – | – | 0.19% | 27 |
|
|
2014
Q4 | $306K | Buy |
+5,734
| New | +$306K | 0.25% | 53 |
|